And compared with CD133-cells with lower expression of miR-130b, CD133+ cells, which were identified as tumor-initiating cells of HCC, had higher expression of miR-130b and thereby possessed a greater ability to form undifferentiated tumor spheroids [23]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.